Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ninian N Lang

Showing results (51-60 of 88) with videos related to

Pageof 9
Sort By:
Biorxiv : the Preprint Server for Biology|June 19, 2024
Arterial effects of anthracycline: structural and inflammatory assessments in non-human primates and lymphoma patients using <sup>18</sup>F-FDG positron emission tomographyStephen Rankin, Caitlin Fountain, Alastair J Gemmell, et al.
Eclinicalmedicine|September 10, 2021
Kidney function and cancer risk: An analysis using creatinine and cystatin C in a cohort studyJennifer S Lees, Frederick Ho, Solange Parra-Soto, et al.
Journal of the American Heart Association|June 18, 2013
Cardiovascular effects of a novel SIRT1 activator, SRT2104, in otherwise healthy cigarette smokersSowmya Venkatasubramanian, Radzi Mohd Noh, Shruti Daga, et al.
Clinical Science (London, England : 1979)|December 16, 2024
Arterial effects of anthracycline: structural and inflammatory assessments in non-human primates and lymphoma patientsStephen Rankin, Caitlin Fountain, Alastair J Gemmell, et al.
Circulation. Heart Failure|September 13, 2022
Reference Ranges for NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) and Risk Factors for Higher NT-proBNP Concentrations in a Large General Population CohortPaul Welsh, Ross T Campbell, Leanne Mooney, et al.
European Heart Journal|January 24, 2023
Temporal trends in the incidence of malignancy in heart failure: a nationwide Danish studyJonas Bruhn, Morten Malmborg, Caroline H Garred, et al.
Circulation. Cardiovascular Imaging|August 10, 2012
Ultrasmall superparamagnetic particles of iron oxide in patients with acute myocardial infarction: early clinical experienceShirjel R Alam, Anoop S V Shah, Jennifer Richards, et al.
Cardio-Oncology (London, England)|May 20, 2026
Cardio-oncology research prioritisation in the United Kingdom: national surveys of health care professionals, patients and carersGerard M Walls, Allyson Arnold, David Austin, et al.
JACC. Cardiooncology|January 13, 2025
Cardiovascular Considerations During Cancer Therapy: Gaps in Evidence and <i>JACC: CardioOncology</i> Expert Panel RecommendationsDarryl P Leong, Sarah Waliany, Husam Abdel-Qadir, et al.
Heart (British Cardiac Society)|April 3, 2025
Vascular endothelial growth factor inhibitor-induced cardiotoxicity: prospective multimodality assessment incorporating cardiovascular magnetic resonance imagingStephen J H Dobbin, Kenneth Mangion, Colin Berry, et al.
Pageof 9

Showing results (51-60 of 88) with videos related to

Sort By:
Pageof 9
Biorxiv : the Preprint Server for Biology|June 19, 2024
Arterial effects of anthracycline: structural and inflammatory assessments in non-human primates and lymphoma patients using <sup>18</sup>F-FDG positron emission tomographyStephen Rankin, Caitlin Fountain, Alastair J Gemmell, et al.
Eclinicalmedicine|September 10, 2021
Kidney function and cancer risk: An analysis using creatinine and cystatin C in a cohort studyJennifer S Lees, Frederick Ho, Solange Parra-Soto, et al.
Journal of the American Heart Association|June 18, 2013
Cardiovascular effects of a novel SIRT1 activator, SRT2104, in otherwise healthy cigarette smokersSowmya Venkatasubramanian, Radzi Mohd Noh, Shruti Daga, et al.
Clinical Science (London, England : 1979)|December 16, 2024
Arterial effects of anthracycline: structural and inflammatory assessments in non-human primates and lymphoma patientsStephen Rankin, Caitlin Fountain, Alastair J Gemmell, et al.
Circulation. Heart Failure|September 13, 2022
Reference Ranges for NT-proBNP (N-Terminal Pro-B-Type Natriuretic Peptide) and Risk Factors for Higher NT-proBNP Concentrations in a Large General Population CohortPaul Welsh, Ross T Campbell, Leanne Mooney, et al.
European Heart Journal|January 24, 2023
Temporal trends in the incidence of malignancy in heart failure: a nationwide Danish studyJonas Bruhn, Morten Malmborg, Caroline H Garred, et al.
Circulation. Cardiovascular Imaging|August 10, 2012
Ultrasmall superparamagnetic particles of iron oxide in patients with acute myocardial infarction: early clinical experienceShirjel R Alam, Anoop S V Shah, Jennifer Richards, et al.
Cardio-Oncology (London, England)|May 20, 2026
Cardio-oncology research prioritisation in the United Kingdom: national surveys of health care professionals, patients and carersGerard M Walls, Allyson Arnold, David Austin, et al.
JACC. Cardiooncology|January 13, 2025
Cardiovascular Considerations During Cancer Therapy: Gaps in Evidence and <i>JACC: CardioOncology</i> Expert Panel RecommendationsDarryl P Leong, Sarah Waliany, Husam Abdel-Qadir, et al.
Heart (British Cardiac Society)|April 3, 2025
Vascular endothelial growth factor inhibitor-induced cardiotoxicity: prospective multimodality assessment incorporating cardiovascular magnetic resonance imagingStephen J H Dobbin, Kenneth Mangion, Colin Berry, et al.
Pageof 9